These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 10546890)

  • 1. Organization of chromatin in cancer cells: role of signalling pathways.
    Davie JR; Samuel SK; Spencer VA; Holth LT; Chadee DN; Peltier CP; Sun JM; Chen HY; Wright JA
    Biochem Cell Biol; 1999; 77(4):265-75. PubMed ID: 10546890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chromatin organization and nuclear microenvironments in cancer cells.
    He S; Dunn KL; Espino PS; Drobic B; Li L; Yu J; Sun JM; Chen HY; Pritchard S; Davie JR
    J Cell Biochem; 2008 Aug; 104(6):2004-15. PubMed ID: 17668423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downregulation of c-fos gene transcription in cells transformed by E1A and cHa-ras oncogenes: a role of sustained activation of MAP/ERK kinase cascade and of inactive chromatin structure at c-fos promoter.
    Kukushkin AN; Abramova MV; Svetlikova SB; Darieva ZA; Pospelova TV; Pospelov VA
    Oncogene; 2002 Jan; 21(5):719-30. PubMed ID: 11850800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation and regulatory parameters of histone modifications.
    Davie JR; Chadee DN
    J Cell Biochem Suppl; 1998; 30-31():203-13. PubMed ID: 9893272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Ras-MAPK signal transduction pathway, cancer and chromatin remodeling.
    Dunn KL; Espino PS; Drobic B; He S; Davie JR
    Biochem Cell Biol; 2005 Feb; 83(1):1-14. PubMed ID: 15746962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Signal transduction pathways and the modification of chromatin structure.
    Davie JR; Spencer VA
    Prog Nucleic Acid Res Mol Biol; 2001; 65():299-340. PubMed ID: 11008491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purification and characterization of chicken erythrocyte histone deacetylase 1.
    Sun JM; Chen HY; Moniwa M; Samuel S; Davie JR
    Biochemistry; 1999 May; 38(18):5939-47. PubMed ID: 10231548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
    Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
    Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of NuA4 histone acetyltransferase activity in transcription and DNA repair by phosphorylation of histone H4.
    Utley RT; Lacoste N; Jobin-Robitaille O; Allard S; Côté J
    Mol Cell Biol; 2005 Sep; 25(18):8179-90. PubMed ID: 16135807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histone deacetylases, transcriptional control, and cancer.
    Cress WD; Seto E
    J Cell Physiol; 2000 Jul; 184(1):1-16. PubMed ID: 10825229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-8 expression is regulated by histone deacetylases through the nuclear factor-kappaB pathway in breast cancer.
    Chavey C; Mühlbauer M; Bossard C; Freund A; Durand S; Jorgensen C; Jobin C; Lazennec G
    Mol Pharmacol; 2008 Nov; 74(5):1359-66. PubMed ID: 18669446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased genomic instability and altered chromosomal protein phosphorylation timing in HRAS-transformed mouse fibroblasts.
    Dunn KL; He S; Wark L; Delcuve GP; Sun JM; Yu Chen H; Mai S; Davie JR
    Genes Chromosomes Cancer; 2009 May; 48(5):397-409. PubMed ID: 19191262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Structure and function of chromatin centered on histone acetyltransferase and histone deacetylase].
    Horikoshi M
    Tanpakushitsu Kakusan Koso; 2000 Jun; 45(9 Suppl):1446-64. PubMed ID: 10879121
    [No Abstract]   [Full Text] [Related]  

  • 14. Role of the ERK/MSK1 signalling pathway in chromatin remodelling and brain responses to drugs of abuse.
    Brami-Cherrier K; Roze E; Girault JA; Betuing S; Caboche J
    J Neurochem; 2009 Mar; 108(6):1323-35. PubMed ID: 19183268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histone modification enzymes: novel targets for cancer drugs.
    Kristeleit R; Stimson L; Workman P; Aherne W
    Expert Opin Emerg Drugs; 2004 May; 9(1):135-54. PubMed ID: 15155140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inducible covalent posttranslational modification of histone H3.
    Bode AM; Dong Z
    Sci STKE; 2005 Apr; 2005(281):re4. PubMed ID: 15855410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Role of the TCF phosphorylation state and the chromatin structure in the negative transcription regulation of the c-fos proto-oncogene in E1A + c-Ha-ras transformed cells].
    Abramova MV; Kukushkin AN; Pospelova TV; Svetlikova SB; Pospelov VA
    Mol Biol (Mosk); 2002; 36(1):66-75. PubMed ID: 11862715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stimulation of the Ras-MAPK pathway leads to independent phosphorylation of histone H3 on serine 10 and 28.
    Dunn KL; Davie JR
    Oncogene; 2005 May; 24(21):3492-502. PubMed ID: 15735677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human papillomavirus type 16 E7 protein increases acetylation of histone H3 in human foreskin keratinocytes.
    Zhang B; Laribee RN; Klemsz MJ; Roman A
    Virology; 2004 Nov; 329(1):189-98. PubMed ID: 15476886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acetylation of non-histone proteins modulates cellular signalling at multiple levels.
    Spange S; Wagner T; Heinzel T; Krämer OH
    Int J Biochem Cell Biol; 2009 Jan; 41(1):185-98. PubMed ID: 18804549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.